GtoPdb is requesting financial support from commercial users. Please see our sustainability page for more information.
| 
                               
                                     
                            
                            
                            
                                 Compound class: 
                                                            Synthetic organic
                                 
                                
                                    
                                        Comment: MRL-248 is a selective, small molecule antagonist of RORγt, an isoform of RORγ (RAR related orphan receptor C), with antiinflammatory potential [1].
                                    
                                 
                            
                            
                          
                                
                                    
                                
                          
                                   
                                   
                                  
                                    
                                    
                                     | 
                                    
                                        
                                         
  | 
                                    
                                
                                |||||||||||||||||||||||||||||||||||
| No information available. | 
Mechanism Of Action and Pharmacodynamic Effects ![]()  | 
                                                        
| MRL-248-induced inhbition of RORγt reduces pro-inflammatory IL-17A secretion from TH17 cells from patients with four inflammatory conditions (ankylosing spondylitis, psoriatic arthritis, rheumatoid arthritis, and inflammatory bowel disease), and reduces transcription of TH17-associated genes [1]. |